437 related articles for article (PubMed ID: 24888982)
1. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system.
Torres R; Martin MC; Garcia A; Cigudosa JC; Ramirez JC; Rodriguez-Perales S
Nat Commun; 2014 Jun; 5():3964. PubMed ID: 24888982
[TBL] [Abstract][Full Text] [Related]
2. Generation of chromosomal translocations that lead to conditional fusion protein expression using CRISPR-Cas9 and homology-directed repair.
Vanoli F; Jasin M
Methods; 2017 May; 121-122():138-145. PubMed ID: 28522325
[TBL] [Abstract][Full Text] [Related]
3. Promiscuous partnerships in Ewing's sarcoma.
Sankar S; Lessnick SL
Cancer Genet; 2011 Jul; 204(7):351-65. PubMed ID: 21872822
[TBL] [Abstract][Full Text] [Related]
4. Generation of conditional oncogenic chromosomal translocations using CRISPR-Cas9 genomic editing and homology-directed repair.
Spraggon L; Martelotto LG; Hmeljak J; Hitchman TD; Wang J; Wang L; Slotkin EK; Fan PD; Reis-Filho JS; Ladanyi M
J Pathol; 2017 May; 242(1):102-112. PubMed ID: 28188619
[TBL] [Abstract][Full Text] [Related]
5. EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.
Kinsey M; Smith R; Iyer AK; McCabe ER; Lessnick SL
Cancer Res; 2009 Dec; 69(23):9047-55. PubMed ID: 19920188
[TBL] [Abstract][Full Text] [Related]
6. Microsatellites as EWS/FLI response elements in Ewing's sarcoma.
Gangwal K; Sankar S; Hollenhorst PC; Kinsey M; Haroldsen SC; Shah AA; Boucher KM; Watkins WS; Jorde LB; Graves BJ; Lessnick SL
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10149-54. PubMed ID: 18626011
[TBL] [Abstract][Full Text] [Related]
7. Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma.
Braunreiter CL; Hancock JD; Coffin CM; Boucher KM; Lessnick SL
Cell Cycle; 2006 Dec; 5(23):2753-9. PubMed ID: 17172842
[TBL] [Abstract][Full Text] [Related]
8. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial generation of variable fusion proteins in the Ewing family of tumours.
Zucman J; Melot T; Desmaze C; Ghysdael J; Plougastel B; Peter M; Zucker JM; Triche TJ; Sheer D; Turc-Carel C
EMBO J; 1993 Dec; 12(12):4481-7. PubMed ID: 8223458
[TBL] [Abstract][Full Text] [Related]
10. Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors.
Desmaze C; Brizard F; Turc-Carel C; Melot T; Delattre O; Thomas G; Aurias A
Cancer Genet Cytogenet; 1997 Aug; 97(1):12-9. PubMed ID: 9242212
[TBL] [Abstract][Full Text] [Related]
11. Junction region of EWS-FLI1 fusion protein has a dominant negative effect in Ewing's sarcoma in vitro.
Jully B; Vijayalakshmi R; Gopal G; Sabitha K; Rajkumar T
BMC Cancer; 2012 Nov; 12():513. PubMed ID: 23145994
[TBL] [Abstract][Full Text] [Related]
12. Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma.
Owen LA; Lessnick SL
Cell Cycle; 2006 Sep; 5(18):2049-53. PubMed ID: 16969112
[TBL] [Abstract][Full Text] [Related]
13. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
Leacock SW; Basse AN; Chandler GL; Kirk AM; Rakheja D; Amatruda JF
Dis Model Mech; 2012 Jan; 5(1):95-106. PubMed ID: 21979944
[TBL] [Abstract][Full Text] [Related]
14. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
Kinsey M; Smith R; Lessnick SL
Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
[TBL] [Abstract][Full Text] [Related]
15. The splicing factor U1C represses EWS/FLI-mediated transactivation.
Knoop LL; Baker SJ
J Biol Chem; 2000 Aug; 275(32):24865-71. PubMed ID: 10827180
[TBL] [Abstract][Full Text] [Related]
16. A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature.
Hancock JD; Lessnick SL
Cell Cycle; 2008 Jan; 7(2):250-6. PubMed ID: 18256529
[TBL] [Abstract][Full Text] [Related]
17. Type 1 (11;22)(q24:q12) translocation is common in Ewing's sarcoma/peripheral neuroectodermal tumour in south Indian patients.
Parija T; Shirley S; Uma S; Rajalekshmy KR; Ayyappan S; Rajkumar T
J Biosci; 2005 Jun; 30(3):371-6. PubMed ID: 16052075
[TBL] [Abstract][Full Text] [Related]
18. Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.
Grohar PJ; Woldemichael GM; Griffin LB; Mendoza A; Chen QR; Yeung C; Currier DG; Davis S; Khanna C; Khan J; McMahon JB; Helman LJ
J Natl Cancer Inst; 2011 Jun; 103(12):962-78. PubMed ID: 21653923
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of chromosome translocations involving EWS and related family members.
Kim J; Pelletier J
Physiol Genomics; 1999 Nov; 1(3):127-38. PubMed ID: 11015571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
